Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



McHale Duncan Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Sold 3,434 shares @ $9.51, valued at $32.7k
Exercised 6,500 restricted stock units @ $0
05/10/2023 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Sold 66,730 shares @ $0.1255, valued at $8.4k
05/09/2023 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Exercised 130,000 restricted stock units @ $0
02/09/2023 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 520,000 restricted stock units @ $0
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/21/2022 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 100,000 options to buy @ $5.05, valued at $505k
01/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2020 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 117,000 options to buy @ $7.06, valued at $826k
05/10/2018 4 McHale Duncan (Chief Medical Officer) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Granted 79,052 options @ $16, valued at $1.3M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy